Heart transplant candidates: Factors influencing waiting list mortality

Irish Medical Journal

Volumn 98, Issue 10, 2005, Pages

  Healy, David G ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VALVE SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IRELAND; MALE; MORTALITY; ORGAN DONOR; PATIENT REFERRAL; PROSPECTIVE STUDY; RESTRICTIVE CARDIOMYOPATHY; SURVIVAL RATE; CHI SQUARE DISTRIBUTION; HEART DISEASE; HOSPITAL ADMISSION; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; WAITING LISTS;

EID: 31844441705     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hosenpud J., Bennett L., Keck B., Boucek M., and Novick R. The registry of the International Society for Heart and Lung Transplantation: seventeenth official report - 2000. J Heart Lung Transplant 2000; 19: 909-931.
2. McManus R., O'Hair, and Beitzinger J. Patients who die awaiting heart transplantation. J Heart Lung Transplant 1993; 12: 159-172.
3. UNOS. The annual report of the US scientific registry of transplant recipients and the organ procurement and transplantation network: transplant data 1988-1991. 1993, UNOS: Richmond, VA.
4. Annual Report of the National Organ Procurement Service 2003 Beaumont Hospital. 2003.
5. Evans R., Manninen D., Garrison L. J., and Maier A. Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986; 255: 1892-1898.
6. Gay W., Cardiac Transplantation., in Surgery of the Chest., Sabiston and Spence, Editors. WB Saunders. 1995.
7. Morgan J., John R., Rao V., Weinberg A., Lee B., Mazzeo P., Flan M., Chen J., Oz M., and Naka Y. Bridging to transplant with the HeartMate left ventricular as device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg 2004; 127: 1309-1316.
8. Packer M., Coats A., Fowler M., Katus H., Krum H., Mohacsi P., Rouleau J., Tendera M., Castaigne A., Roecker E., Schultz M., DeMets D., and Group C. P. R. C. S. S. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
9. Flather M., Yusuf S., Kober L., Pfeffer M., Hall A., Murray G., Torp-Pedersen C., Ball S., Pogue J., Moye L., and Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure of left-ventricular dysfunction: a systemic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group. Lancet 2000; 355: 1575-1581.
10. Pitt B., Zannad F., Remme W., Cody R., Castaigne A., Perez A., Palensky J., and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999; 341: 709-717.
11. Alderman E., Fischer L., Litwin P., Kaiser G., Myers W., Maynard C., Levine F., and Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-795.
12. Coats A. MADIT II, the Multi-center Automatic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence based credentials. Int J Cardiol 2002; 82: 1-5.
13. Awad I., Dwyer R., Rohan D., Fanning R., Keane E., Counihan A., and Cunningham P. Brain death and organ donation: an audit in the Irish National Transplantation and Neurosurgical Centre. Ir Med J 2004; 97: 77-79.
14. Matesanz R. Factors influencing the adaptation of the Spanish model of organ donation. Transpl Int 2003; 16: 736-741.